Jose Carlos Benitez

Instituto de Investigación Biomédica de Málaga

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Antonin LEVY, MD, PhD

Université Paris-Saclay

FRANCE

View details

Isabel Barragan

Karolinska Institutet

SWEDEN

View details

LAURA MEZQUITA

University of Barcelona

SPAIN

View details

Boris Duchemann

FRANCE

View details

Andrea De Giglio

University of Bologna

ITALY

View details

Joaquim Bosch-Barrera

Professor Associat Doctor

Universitat de Girona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jose Carlos Benitez

Research Interests

Explore related searches

Contact this professor

Articles (10)

Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

New Immunotherapy Combinations Enter the Battlefield of Malignant Mesothelioma.

Late phase 1 studies: concepts and outcomes.

Central Nervous System Metastases in Thymic Epithelial Tumors: A Brief Report of Real-World Insight From RYTHMIC.

Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy.

Collaborators (6)

Antonin LEVY, MD, PhD

Isabel Barragan

LAURA MEZQUITA

Boris Duchemann

Andrea De Giglio

Joaquim Bosch-Barrera

Make your next move.